[#item_full_content]
Author:
Orthogon Therapeutics Closes Oversubscribed $5.2M Financing to Advance First Oral Therapy for BK Polyomavirus
[#item_full_content]CANTON, Mass.–(BUSINESS WIRE)– #BKVAN–Orthogon Therapeutics, a developer of novel antiviral medicines, today announced the closing of…
FDA Grants Breakthrough Device Designation to MeMed Severity Test for Patients with Suspected Sepsis
[#item_full_content]ANDOVER, Mass. & HAIFA, Israel–(BUSINESS WIRE)– #BDD–This designation advances the management of acute infections and sepsis…
PricingDirect and Aumni Partner to Deliver Independent Valuations for Private Equity Securities
[#item_full_content]NEW YORK & SAN FRANCISCO–(BUSINESS WIRE)–PricingDirect, Inc. (“PricingDirect”) and Aumni, Inc. (“Aumni”), both wholly owned subsidiaries…